CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 233 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $82 | -99.9% | 3,645 | -3.3% | 0.00% | 0.0% |
| Q3 2022 | $84,000 | 0.0% | 3,770 | +1.7% | 0.00% | -33.3% |
| Q2 2022 | $84,000 | -23.6% | 3,706 | -25.6% | 0.00% | +200.0% |
| Q1 2022 | $110,000 | +307.4% | 4,984 | +297.8% | 0.00% | 0.0% |
| Q4 2021 | $27,000 | +8.0% | 1,253 | +8.7% | 0.00% | 0.0% |
| Q3 2021 | $25,000 | +525.0% | 1,153 | +639.1% | 0.00% | – |
| Q2 2021 | $4,000 | – | 156 | – | 0.00% | – |
| Q1 2021 | $0 | – | 0 | – | 0.00% | – |
| Q4 2020 | $0 | – | 0 | – | 0.00% | – |
| Q3 2020 | $0 | – | 0 | – | 0.00% | – |
| Q2 2020 | $0 | – | 0 | – | 0.00% | – |
| Q1 2020 | $0 | – | 0 | – | 0.00% | – |
| Q4 2019 | $0 | – | 0 | – | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q4 2018 | $4,000 | -66.7% | 275 | -68.6% | 0.00% | – |
| Q3 2018 | $12,000 | +140.0% | 876 | +172.0% | 0.00% | – |
| Q2 2018 | $5,000 | – | 322 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,609,429 | $55,961,000 | 3.12% |
| INVESTOR AB | 1,835,974 | $11,934,000 | 0.86% |
| GLOBEFLEX CAPITAL L P | 244,183 | $1,587,000 | 0.40% |
| Campbell & CO Investment Adviser LLC | 21,446 | $139,000 | 0.37% |
| Birchview Capital, LP | 80,000 | $520,000 | 0.30% |
| FEDERATED HERMES, INC. | 13,879,968 | $90,220,000 | 0.26% |
| MENTA CAPITAL LLC | 388,582 | $2,526,000 | 0.24% |
| Sitrin Capital Management LLC | 40,000 | $260,000 | 0.20% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 172,389 | $1,121,000 | 0.18% |
| GSA CAPITAL PARTNERS LLP | 384,976 | $2,502,000 | 0.13% |